Tianyu Lin
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression.
Journal: Cell death & disease
Published: June 10, 2025
Programmed Cell Death Protein 10 (PDCD10) Regulates Vesicle Trafficking and Contributes to the Progression of Clear Cell Renal Cell Carcinoma.
Journal: Journal of extracellular vesicles
Published: January 12, 2025
ABCG1 promotes the proliferation and migration of clear cell renal cell carcinoma and reduces its apoptosis.
Journal: International journal of medical sciences
Published: November 16, 2024
Transcription factor MAZ activates the transcription of hypomethylated TYMP in ccRCC.
Journal: Functional & integrative genomics
Published: October 06, 2024
Rho GTPase-activating protein 4 is upregulated in Kidney Renal Clear Cell Carcinoma and associated with poor prognosis and immune infiltration.
Journal: Cancer biomarkers : section A of Disease markers
Published: June 21, 2024
p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization.
Journal: International journal of biological sciences
Published: March 17, 2023
G3BP1 regulates breast cancer cell proliferation and metastasis by modulating PKCζ.
Journal: Frontiers in genetics
Published: September 02, 2022
A novel Granzymes and miRNA nanocapsules co-delivery system for tumor suppression.
Journal: Biomedical physics & engineering express
Published: July 15, 2022
C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.
Journal: International journal of medical sciences
Published: February 27, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026